(18 days)
No
The document describes a combined PET/CT scanner with hardware and software modifications focused on improving CT performance and integration. There is no mention of AI or ML in the intended use, device description, or performance studies.
No.
This device is an imaging system designed to diagnose various metabolic and physiologic functions and produce cross-sectional images, not to treat conditions.
Yes
This device is a combined PET/CT scanner intended to image and measure the distribution of injected radiopharmaceuticals and produce cross-sectional images of the body. These functions are used to determine various metabolic and physiological functions, and to provide anatomical and metabolic information, which are all diagnostic activities. The text explicitly states "most standard CT and PET clinical diagnostic protocols to be available on the PET/CT system."
No
The device description clearly outlines a physical scanner system with hardware components including a gantry structure, patient handling system, PET component, and CT component. While it mentions software as part of the system, it is not a software-only device.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The ECAT LSO PET/CT 16 is an imaging system that uses injected radiopharmaceuticals and X-rays to create images of the human body. It directly images the distribution of substances within the body and produces cross-sectional anatomical images.
- Lack of Specimen Analysis: The device does not analyze specimens taken from the body. It works by imaging the body itself.
The device is a medical imaging system used for diagnostic purposes, but it falls under the category of medical devices that image the body directly, not IVDs.
N/A
Intended Use / Indications for Use
The ECAT LSO PET/CT 16 tomographic scanner system is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner. The ECAT LSO PET/CT 16 scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)
Product codes
90 KPS
Device Description
The ECAT LSO PET/CT 16 is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner. This dual modality tomograph is a modified version of the ECAT LSO PET/CT (K013504) and will utilize the same PET component as the ECAT LSO PET/CT scanner. However, in place of the Siemens P10 SOMATOM EMOTION CT component that uses a single or dual row of X-Ray detectors, the ECAT LSO PET/CT 16 will be configured with the Siemens P30 SOMATOM SENSATION CT, utilizing 24 rows of X-Ray detectors and having the capability to acquire 16 slices of X-Ray data simultaneously. As with the unmodified system, 2D PET acquisition septa and the PET transmission sources are not incorporated in the modified ECAT LSO PET/CT. PET emission data is acquired only in 3D mode and PET attenuation correction map data are obtained from the CT. The PET and CT components are contained within a unified housing similar to the original ECAT LSO PET/CT to create an integrated, PET, CT, and combined PET/CT, tomographic imaging system.
The ECAT LSO PET/CT 16 gantry structure, patient handling system (PHS), advanced computational system (ACS 3), workstation and software will be similar to the ECAT LSO PET/CT with only minor modifications. The gantry's unified housing has been modified cosmetically and enlarged to accommodate the increased size of the SOMATOM P30 CT gantry. In addition, the patient handling system (PHS) has been modified to ensure adequate dual scan coverage for PET and CT patient scanning, with the increased axial depth of the new SOMATOM P30 CT gantry. The high performance Siemens P30 SOMATOM SENSATION CT with 16 slice capability provides for faster and higher quality CT acquisitions but does not otherwise affect performance of the ECAT LSO PET/CT 16.
The ECAT LSO PET/CT 16 scanner is intended for use primarily as a clinical, whole-body oncology machine with high-end spiral CT performance and fast patient-throughput clinical PET performance. As on the original system, the CT component will also enhance PET scans by allowing fast, essentially noise-free, attenuation correction for PET studies and by providing precise anatomical reference through fused PET and CT images. In addition, the ECAT LSO PET/CT 16 will retain mechanical isolation and independent functionality of the PET and CT scanning systems, thereby allowing for most standard CT and PET clinical diagnostic protocols to be available on the PET/CT system.
The purpose of introducing this modified ECAT LSO PET/CT 16 system is to offer a combined PET and CT tomograph having very high CT performance with the fast throughput of the ECAT ACCEL PET, as a higher performance alternative to the presently distributed ECAT LSO PET/CT system.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Positron Emission Tomography (PET), X-ray Computed Tomography (CT)
Anatomical Site
human body (whole-body oncology machine)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
appropriately trained health care professionals, clinical setting
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The combined PET/CT system has been tested by CPS and found to meet its predetermined performance requirements.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
8 2002 NOV
510(k) SUMMARY
[As required by 21 CFR 807.87(h)]
Identification of Submitter
Submitter:
Contact Person:
Telephone No: Fax No: Date of preparation:
Identification of the Product
Device Proprietary Name: Common Name:
Classification Name:
CTI PET Systems, Inc. 810 Innovation Drive Knoxville, TN 37932 William Skremsky Senior Regulatory Affairs Specialist (865) 218-2522 (865) 218-3000 October 18, 2002
ECAT LSO PET/CT 16 Combination Positron Emission Tomography (PET) and X-Ray Computed Tomography (CT) Emission Computed Tomography System per 21 CFR 892.1200
Marketed Devices to Which Equivalence is Claimed
| Device | Manufacturer | 510(k) Number |
|---|---|---|
| ECAT LSO PET/CT | CTI PET Systems (CPS) | K013504 |
Device Description and Comparison to the Unmodified Device
The ECAT LSO PET/CT 16 is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner. This dual modality tomograph is a modified version of the ECAT LSO PET/CT (K013504) and will utilize the same PET component as the ECAT LSO PET/CT scanner. However, in place of the Siemens P10 SOMATOM EMOTION CT component that uses a single or dual row of X-Ray detectors, the ECAT LSO PET/CT 16 will be configured with the Siemens P30 SOMATOM SENSATION CT, utilizing 24 rows of X-Ray detectors and having the capability to acquire 16 slices of X-Ray data simultaneously. As with the unmodified system, 2D PET acquisition septa and the PET transmission sources are not incorporated in the modified ECAT LSO PET/CT. PET emission data is acquired only in 3D mode and PET attenuation correction map data are obtained from the CT. The PET and CT components are contained within a unified housing similar to the original ECAT LSO PET/CT to create an integrated, PET, CT, and combined PET/CT, tomographic imaging system.
The ECAT LSO PET/CT 16 gantry structure, patient handling system (PHS), advanced computational system (ACS 3), workstation and software will be similar to the ECAT LSO PET/CT with only minor modifications. The gantry's unified housing has been modified cosmetically and enlarged to accommodate the increased size of the SOMATOM P30 CT gantry. In addition, the patient handling system (PHS) has been modified to ensure adequate
Kestrel 510(k) Summary revised
1
510(k) Summary ECAT LSO PET/CT Scanner p. 2
dual scan coverage for PET and CT patient scanning, with the increased axial depth of the new SOMATOM P30 CT gantry. The high performance Siemens P30 SOMATOM SENSATION CT with 16 slice capability provides for faster and higher quality CT acquisitions but does not otherwise affect performance of the ECAT LSO PET/CT 16.
The ECAT LSO PET/CT 16 scanner is intended for use primarily as a clinical, whole-body oncology machine with high-end spiral CT performance and fast patient-throughput clinical PET performance. As on the original system, the CT component will also enhance PET scans by allowing fast, essentially noise-free, attenuation correction for PET studies and by providing precise anatomical reference through fused PET and CT images. In addition, the ECAT LSO PET/CT 16 will retain mechanical isolation and independent functionality of the PET and CT scanning systems, thereby allowing for most standard CT and PET clinical diagnostic protocols to be available on the PET/CT system.
The purpose of introducing this modified ECAT LSO PET/CT 16 system is to offer a combined PET and CT tomograph having very high CT performance with the fast throughput of the ECAT ACCEL PET, as a higher performance alternative to the presently distributed ECAT LSO PET/CT system.
Intended Use
The CPS ECAT LSO PET/CT 16 system is a combined positron emission tomography (PET) and Xray computed tomography (CT) scanner. This PET/CT scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)
Safety and Effectiveness
The CPS ECAT LSO PET/CT 16 system has been designed to comply with applicable industry safety standards for this type of medical equipment including the international standard IEC 60601-1, General Requirements for the Safety Electrical Medical Equipment and UL 187, the X-Ray Equipment Standard for Safety. The CT component has been tested and meets the requirements of the applicable US Federal Performance Standards and regulations of 21CFR 1020.30 and 1020.33. The PET component is unmodified from the previously cleared ECAT LSO PET/CT (K013504). The combined PET/CT system has been tested by CPS and found to meet its predetermined performance requirements.
2
510(k) Summary ECAT LSO PET/CT Scanner p. 3
Substantial Equivalence Determination
In the opinion of CPS, the ECAT LSO PET/CT 16 system utilizes the same scientific technology as the unmodified ECAT LSO PET/CT system and raises no new questions with regard to its safety and effectiveness. Therefore, we believe the modified ECAT LSO PET/CT 16 is substantially equivalent to the unmodified ECAT LSO PET/CT with respect to design, material and composition, energy source, and radiation safety characteristics.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows a black and white logo. The logo is circular and contains the words "Department of Human" around the edge. Inside the circle is a stylized image of an eagle's head and neck. The eagle's head is facing to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. William Skremsky Senior Regulatory Affairs Specialist CTI PET Systems, Inc. 810 Innovation Drive KNOXVILLE TN 37932
Re: K023518
Trade/Device Name: ECAT LSO PET/CT 16 Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system
Regulatory Class: II Product Code: 90 KPS Dated: October 18, 2002 Received: October 21, 2002
Dear Mr. Skremsky:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (sec above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
4
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Nancy C. Snogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
Page 2
5
Page / of /
510(k) Number (if known):
K0235/8
Device Name: ECAT LSO PET/CT 16
Indications for Use:
The ECAT LSO PET/CT 16 tomographic scanner system is a combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner. The ECAT LSO PET/CT 16 scanner is intended to be utilized by appropriately trained health care professionals to 1) image and measure the distribution of injected positron emitting radiopharmaceuticals in humans for the purpose of determining various metabolic (molecular) and physiologic functions within the human body; and 2) to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial plane taken at different angles or spiral planes* taken at different angles.
The PET and the CT functions of this system can also be used in combination to provide high resolution, noise free CT attenuation correction maps for PET images and, additionally, utilized to produce fused CT and PET images, providing detailed anatomic and metabolic function information in a single image.
(*spiral planes: the axial planes resulted from the continuous rotation of detectors and x-ray tube and the simultaneous translation of the patient.)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use
| (Per 21 CFR 801.109) | ✓ | OR |
|---|---|---|
| [Signature] |
Division of Reproductive. Abdomi
and Radiological Devices
(Division Sign-Off)
510(k) Number _
Over-The-Counter Use
(Optional Format 1-2-96)
3